SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-244313
Filing Date
2018-08-09
Accepted
2018-08-09 16:08:06
Documents
79
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d593709d10q.htm 10-Q 993351
2 EX-31.1 d593709dex311.htm EX-31.1 9668
3 EX-31.2 d593709dex312.htm EX-31.2 9674
4 EX-32.1 d593709dex321.htm EX-32.1 4313
5 EX-32.2 d593709dex322.htm EX-32.2 4304
  Complete submission text file 0001193125-18-244313.txt   6104393

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tbio-20180630.xml EX-101.INS 1030803
7 XBRL TAXONOMY EXTENSION SCHEMA tbio-20180630.xsd EX-101.SCH 70685
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tbio-20180630_cal.xml EX-101.CAL 63758
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tbio-20180630_def.xml EX-101.DEF 450376
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20180630_lab.xml EX-101.LAB 555869
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20180630_pre.xml EX-101.PRE 519350
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38550 | Film No.: 181005086
SIC: 2836 Biological Products, (No Diagnostic Substances)